A new study reveals how bone marrow stem cell niche generation is regulated, which could lead to improvements in stem cell transplantation for the treatment of blood diseases.
Arthur G. Palmer and Oliver Hobert of the Department of Biochemistry & Molecular Biophysics were selected in recognition of their distinguished and continuing achievements in research.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
An analysis of more than 40,000 primary sensory neurons in the skin has found multiple different types, each sensing a more complex range of stimuli than previously assumed.
Doctoral students from VP&S and Mailman participated in a university-wide competition designed to help students develop communication skills for future careers. Two shared top honors.
Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.